The latest biopharma awards press releases and news

NEWSROOM

IMAPAC Applauds Biocair on Best Cell & Gene Therapy Supplier Award - APAC and Best Cell & Gene Therapy Supplier Award - Supply Chain Excellence at Asia Pacific Cell & Gene Therapy Excellence Awards 2023

Singapore, September 14, 2023 – IMAPAC, a leading event management company specializing in the biopharmaceutical industry, congratulates Biocair on receiving the “Best Cell & Gene Therapy Supplier Award – Supply Chain Excellence” and “Best Cell & Gene Therapy Supplier Award – APAC” at Asia Pacific Cell & Gene Therapy Excellence Awards.

Since 1986, Biocair has established a global reputation as a leading GDP logistics specialist within the pharmaceutical, biotechnology and life sciences sectors. Biocair has built up a unique, client-centric approach by employing scientists in front-line logistics positions and assembling a team of best-in-class industry experts in quality, cold chain and regulatory compliance. Biocair focuses on providing the most comprehensive time-sensitive and temperature-controlled logistics services available whilst delivering flexible, tailored, cost-effective solutions to all its clients. It is committed to delivering complete end-to-end logistics solutions through its 24/7 operation and global network spanning across Europe, Africa, Asia and the Americas. Biocair employs over 600 people worldwide and provides specialist logistics services to more than 160 countries through a global network of partners. Biocair’s offices are located in the UK, France, Belgium, Germany, USA, South Africa, China, Singapore and India. In 2012 Biocair was acquired as an autonomous division by Geopost. Geopost is the largest parcel delivery network in Europe, which posted sales of €15.6 billion in 2022. Geopost is a holding company owned by Groupe La Poste.

Kevin Xu, APAC General Manager of Biocair stated, “We are honoured to be recognised by our industry peers for our contributions to the cell and gene therapy supply chain. The award is a testament to the knowledge, care and teamwork shown by Biocair’s global team of logistics experts. For over 35 years Biocair remains dedicated to moving science forward and improving the lives of patients globally by working closely with the global scientific community to develop innovative logistics solutions. Thank you to everyone who voted for Biocair – your support is greatly appreciated, and we look forward to continue working with you”

IMAPAC Awards helps Biocair to strengthen reputation as being the logistics specialist for cell and gene therapy and serves to recognise the outstanding commitment of our Biocair colleagues in moving science forward. Biocair will continue to develop its global presence across a range of strategic locations as well as further developing its links with other supply chain partners, including technology and packaging experts.

About IMAPAC

IMAPAC is a leading event management company specializing in the biopharmaceutical industry. With over 12 years of experience, IMAPAC has successfully organized more than 50 industry events, attracting over 15,000 participants from around the world. IMAPAC’s events are renowned for their high-quality content, prestigious speakers, and networking opportunities.

Contacts

Jegan Sanska
IMAPAC
[email protected]

RELATED CONTENT

IMAPAC has successfully held the Asia-Pacific Bioprocessing Excellence Awards 2023, recognizing outstanding achievements and contributions in bioprocessing. The awards ceremony attracted over 80 participants from more than 40 biopharmaceutical companies across the Asia-Pacific region, with 53 categories such as Best Biomanufacturing Team and Best Emerging Biotech Company.

The Biopharma Logistics and Supply Chain Excellence Awards (BLSA) 2023 APAC recognized outstanding achievements in biologistics across Asia at their 2023 ceremony, held alongside the 7th BioLogistics World Asia event. The awards celebrate exceptional personnel, organizations, and technologies in the industry and aim to inspire future innovators. 

The Biopharma R&D and Clinical Trials Awards (BRCTA) 2023 recognized exceptional Asian clinical trials leaders, organizations, and technologies over the past year. The awards include various categories such as Excellence Awards, Individual Awards, and Team Awards, identifying the best of the best in the industry.